Paul de Souza

Professor Paul de Souza is a leading academic at the University of Sydney, specializing in oncology with a focus on biomarkers, liquid biopsies, and personalized cancer therapy. His research spans prostate cancer, colorectal cancer, and glioblastoma, emphasizing circulating tumor cells and microRNA profiling for treatment response prediction.

• 2024: Published studies on platinum-based chemotherapy for triple-negative breast cancer and cisplatin-resistant colorectal cancer.
• 2023: Investigated alcohol’s impact on quality of life in Australian populations and phytochemical combinations for prostate cancer.

His work on liquid biopsies (2022) explores their role in immune checkpoint inhibitor therapy, while meta-analyses address CCND1 amplification in breast cancer and AR-V7 in prostate cancer. Clinical trials like RESIRT (2022) highlight his contributions to renal cell carcinoma treatment. No scientific awards are explicitly mentioned, but his 15 recent publications reflect ongoing leadership in translational oncology.